|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
|
MXPA05012377A
(es)
|
2003-05-15 |
2006-05-25 |
Arqule Inc |
Derivados de imidazotiazoles e imidazoxazol como inhibidores de p38.
|
|
EP1867644B1
(en)
*
|
2003-07-24 |
2009-05-20 |
Euro-Celtique S.A. |
Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
|
|
SI1867644T1
(sl)
*
|
2003-07-24 |
2009-10-31 |
Euro Celtique Sa |
Heteroaril-tetrahidropiperidilne spojine, koristne za zdravljenje ali preprečevanje bolečine
|
|
JP4866610B2
(ja)
*
|
2003-08-18 |
2012-02-01 |
富士フイルムファインケミカルズ株式会社 |
ピリジルテトラヒドロピリジン類およびピリジルピペリジン類
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
DE10360745A1
(de)
*
|
2003-12-23 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7319108B2
(en)
|
2004-01-25 |
2008-01-15 |
Sanofi-Aventis Deutschland Gmbh |
Aryl-substituted heterocycles, process for their preparation and their use as medicaments
|
|
DE102004003812A1
(de)
*
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
WO2006010082A1
(en)
*
|
2004-07-08 |
2006-01-26 |
Arqule, Inc. |
1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
CA2580762A1
(en)
*
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
|
CA2582327A1
(en)
*
|
2004-10-01 |
2006-04-13 |
Takao Suzuki |
2-arylcarboxamide-nitrogeneous heterocycle compound
|
|
CN101094846A
(zh)
*
|
2004-10-18 |
2007-12-26 |
伊莱利利公司 |
用作mglur3受体拮抗剂的1－(杂)芳基－3－氨基－吡咯烷衍生物
|
|
JP2008517064A
(ja)
|
2004-10-19 |
2008-05-22 |
アークル インコーポレイテッド |
Ｐ３８ｍａｐキナーゼのイミダゾオキサゾールおよびイミダゾチアゾール阻害剤の合成
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
JPWO2006054793A1
(ja)
*
|
2004-11-19 |
2008-06-05 |
財団法人新産業創造研究機構 |
ベンゾフラン化合物、およびそれを含有してなる医薬組成物
|
|
AR055831A1
(es)
|
2004-12-30 |
2007-09-12 |
Janssen Pharmaceutica Nv |
Pepirazinilureas y piperidinilureas como moduladores de hidrolasa de amida de acidos grasos
|
|
TWI444187B
(zh)
|
2005-01-25 |
2014-07-11 |
Synta Pharmaceuticals Corp |
用於炎症及免疫相關用途之噻吩化合物
|
|
CN101273026A
(zh)
|
2005-09-30 |
2008-09-24 |
霍夫曼-拉罗奇有限公司 |
作为mch受体拮抗剂的茚满衍生物
|
|
CN102633783A
(zh)
|
2006-02-10 |
2012-08-15 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
WO2007093365A2
(en)
*
|
2006-02-15 |
2007-08-23 |
Sanofi-Aventis |
Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
|
EP1986646A1
(en)
*
|
2006-02-15 |
2008-11-05 |
Sanofi-Aventis |
Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
|
|
PE20080359A1
(es)
|
2006-04-19 |
2008-06-06 |
Novartis Ag |
Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r
|
|
JP5182088B2
(ja)
*
|
2006-04-19 |
2013-04-10 |
アステラス製薬株式会社 |
アゾールカルボキサミド誘導体
|
|
UA93548C2
(uk)
|
2006-05-05 |
2011-02-25 |
Айерем Елелсі |
Сполуки та композиції як модулятори хеджхогівського сигнального шляху
|
|
BRPI0710331A2
(pt)
|
2006-05-08 |
2012-03-20 |
Ariad Pharmaceuticals, Inc |
Compostos heteroarila monocíclicos para tratamento de câncer e composição
|
|
AU2007249924B2
(en)
*
|
2006-05-08 |
2013-07-04 |
Ariad Pharmaceuticals, Inc. |
Acetylenic heteroaryl compounds
|
|
JP2010500300A
(ja)
|
2006-08-08 |
2010-01-07 |
サノフィ−アベンティス |
アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
|
|
JP2010501567A
(ja)
*
|
2006-08-24 |
2010-01-21 |
ノバルティス アクチエンゲゼルシャフト |
代謝系、心血管系および他の障害の処置のためのステアロイル−ＣｏＡ不飽和化酵素（ＳＣＤ）阻害剤としての２−（ピラジン−２−イル）−チアゾールおよび２−（１Ｈ−ピラゾール−３−イル）チアゾール誘導体ならびに関連化合物
|
|
BRPI0716532A2
(pt)
*
|
2006-09-11 |
2013-09-24 |
Glaxo Group Ltd |
compostos azabicÍclios como inidores de reabsorÇço de monoaminas
|
|
EP2066642A1
(en)
*
|
2006-09-25 |
2009-06-10 |
Arete Therapeutics, INC. |
Soluble epoxide hydrolase inhibitors
|
|
AR063311A1
(es)
*
|
2006-10-18 |
2009-01-21 |
Novartis Ag |
Compuestos organicos
|
|
AU2008205252B2
(en)
*
|
2007-01-09 |
2013-02-21 |
Amgen Inc. |
Bis-aryl amide derivatives useful for the treatment of cancer
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
GB0706793D0
(en)
*
|
2007-04-05 |
2007-05-16 |
Evotec Ag |
Compounds
|
|
ES2536406T3
(es)
*
|
2007-06-08 |
2015-05-25 |
Janssen Pharmaceutica, N.V. |
Derivados de piperidina/piperazina
|
|
JO2972B1
(en)
|
2007-06-08 |
2016-03-15 |
جانسين فارماسوتيكا ان. في |
Piperidine / piperazine derivatives
|
|
AU2008258560C1
(en)
|
2007-06-08 |
2014-04-10 |
Janssen Pharmaceutica N.V. |
Piperidine/piperazine derivatives
|
|
ES2558152T3
(es)
|
2007-06-08 |
2016-02-02 |
Janssen Pharmaceutica, N.V. |
Derivados de piperidina/piperazina
|
|
TWI452044B
(zh)
*
|
2007-06-15 |
2014-09-11 |
Mitsubishi Tanabe Pharma Corp |
嗎啉衍生物
|
|
TW200918521A
(en)
*
|
2007-08-31 |
2009-05-01 |
Astrazeneca Ab |
Heterocyclic amides and methods of use thereof
|
|
PL2203439T3
(pl)
|
2007-09-14 |
2011-06-30 |
Addex Pharmaceuticals Sa |
1',3'-dipodstawione-4-fenylo-3,4,5,6-tetrahydro-2H, 1'H-[1, 4']bipirydynylo-2'-ketony
|
|
US8252937B2
(en)
|
2007-09-14 |
2012-08-28 |
Janssen Pharmaceuticals, Inc. |
1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
|
|
US8722894B2
(en)
|
2007-09-14 |
2014-05-13 |
Janssen Pharmaceuticals, Inc. |
1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
|
|
EP2212282B1
(en)
*
|
2007-10-17 |
2011-09-21 |
Sanofi |
Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
|
|
CN101903340B
(zh)
*
|
2007-10-17 |
2013-03-27 |
赛诺菲-安万特 |
取代的n-苯基联吡咯烷羧酰胺及其治疗用途
|
|
WO2009052068A1
(en)
*
|
2007-10-17 |
2009-04-23 |
Sanofi-Aventis |
Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
|
|
CN101903342B
(zh)
*
|
2007-10-17 |
2012-11-21 |
赛诺菲-安万特 |
取代的n-苯基-吡咯烷基甲基吡咯烷酰胺及其作为组胺h3受体调节剂的治疗用途
|
|
RU2461551C2
(ru)
|
2007-10-24 |
2012-09-20 |
Астеллас Фарма Инк. |
Азолкарбоксамидное соединение или его фармацевтически приемлемая соль
|
|
RU2492170C9
(ru)
|
2007-11-14 |
2013-12-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2
|
|
EP2070916A1
(de)
|
2007-12-10 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
2-Aryl-thiazol-4-carbonsäureamid-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
|
EP2070924A1
(de)
|
2007-12-10 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel
|
|
EP2070925A1
(de)
|
2007-12-10 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Neue 2-substituierte Tiazol-4-carbonsäureamid-Derivative deren Herstellung und Verwendung als Arzneimittel
|
|
RU2364597C1
(ru)
|
2007-12-14 |
2009-08-20 |
Андрей Александрович Иващенко |
ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
|
|
ES2617619T3
(es)
*
|
2008-06-05 |
2017-06-19 |
Janssen Pharmaceutica, N.V. |
Combinaciones de fármacos que comprenden un inhibidor de DGAT y un agonista de PPAR
|
|
WO2010003624A2
(en)
|
2008-07-09 |
2010-01-14 |
Sanofi-Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
|
JP5547194B2
(ja)
|
2008-09-02 |
2014-07-09 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
|
|
EP2334181A4
(en)
*
|
2008-09-16 |
2012-03-14 |
Merck Sharp & Dohme |
METABOTROPE GLUTAMATE R4 LIGANDS FROM PHTHALIMIDE
|
|
JP2012006837A
(ja)
*
|
2008-09-30 |
2012-01-12 |
Mochida Pharmaceut Co Ltd |
２−インドールアクリルアミド類縁体
|
|
RU2517181C2
(ru)
|
2008-10-16 |
2014-05-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов
|
|
EP2365809B8
(en)
|
2008-11-12 |
2018-10-10 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines and derivatives as kinase inhibitors
|
|
WO2010060589A1
(en)
|
2008-11-28 |
2010-06-03 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
|
AR074466A1
(es)
*
|
2008-12-05 |
2011-01-19 |
Sanofi Aventis |
Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3.
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
UA103918C2
(en)
|
2009-03-02 |
2013-12-10 |
Айерем Элелси |
N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
|
|
JP5685181B2
(ja)
*
|
2009-03-05 |
2015-03-18 |
塩野義製薬株式会社 |
Ｎｐｙｙ５受容体拮抗作用を有するシクロヘキサン誘導体
|
|
JP5642661B2
(ja)
|
2009-03-05 |
2014-12-17 |
塩野義製薬株式会社 |
Ｎｐｙｙ５受容体拮抗作用を有するピペリジンおよびピロリジン誘導体
|
|
MY153912A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
1, 2, 4,-triazolo[4,3-a[pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
CN102439008B
(zh)
|
2009-05-12 |
2015-04-29 |
杨森制药有限公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
MX2012001729A
(es)
|
2009-08-26 |
2012-06-13 |
Sanofi Sa |
Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
|
|
US20120225097A1
(en)
|
2009-11-12 |
2012-09-06 |
Hawryluk Natalie A |
Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
|
|
US9452980B2
(en)
*
|
2009-12-22 |
2016-09-27 |
Hoffmann-La Roche Inc. |
Substituted benzamides
|
|
UA108233C2
(uk)
|
2010-05-03 |
2015-04-10 |
|
Модулятори активності гідролази амідів жирних кислот
|
|
AR083718A1
(es)
*
|
2010-05-11 |
2013-03-20 |
Sanofi Aventis |
Fenil cicloalquil pirrolidina (piperidina) espirolactamas y amidas sustituidas, preparacion y uso terapeutico de las mismas
|
|
WO2011143162A1
(en)
*
|
2010-05-11 |
2011-11-17 |
Sanofi |
Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
|
|
JP5833105B2
(ja)
*
|
2010-05-11 |
2015-12-16 |
サノフイ |
置換ｎ−ヘテロアリールスピロラクタムビピロリジン類、その製造及び治療的使用
|
|
UY33469A
(es)
|
2010-06-29 |
2012-01-31 |
Irm Llc Y Novartis Ag |
Composiciones y metodos para modular la via de señalizacion de wnt
|
|
PL2649069T3
(pl)
|
2010-11-08 |
2016-01-29 |
Janssen Pharmaceuticals Inc |
Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
|
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
CN103261195B
(zh)
|
2010-11-08 |
2015-09-02 |
杨森制药公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
US8828995B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
|
EP2683705B1
(de)
|
2011-03-08 |
2015-04-22 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683701B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683698B1
(de)
|
2011-03-08 |
2017-10-04 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683702B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012170554A1
(en)
|
2011-06-06 |
2012-12-13 |
Theodore Mark Kamenecka |
N-biphenylmethylindole modulators of pparg
|
|
WO2012170561A1
(en)
*
|
2011-06-06 |
2012-12-13 |
The Scripps Research Institute (T.S.R.I.) |
N-benzylindole modulators of pparg
|
|
WO2013078240A1
(en)
|
2011-11-22 |
2013-05-30 |
Ripka Amy S |
N-biphenylmethylbenzimidazole modulators of pparg
|
|
US9102669B2
(en)
|
2011-12-06 |
2015-08-11 |
Janssen Pharmaceutica Nv |
Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors
|
|
WO2013085954A1
(en)
|
2011-12-06 |
2013-06-13 |
Janssen Pharmaceutica Nv |
Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors
|
|
CA2873075A1
(en)
*
|
2012-05-11 |
2013-07-14 |
Abbvie Inc. |
Nampt inhibitors
|
|
CA2890002A1
(en)
*
|
2012-11-05 |
2014-05-08 |
Nant Holdings Ip, Llc |
Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
|
|
AR094929A1
(es)
|
2013-02-28 |
2015-09-09 |
Bristol Myers Squibb Co |
Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
|
|
WO2014134391A1
(en)
|
2013-02-28 |
2014-09-04 |
Bristol-Myers Squibb Company |
Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
HUE053734T2
(hu)
|
2014-01-21 |
2021-07-28 |
Janssen Pharmaceutica Nv |
2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk
|
|
KR20220049612A
(ko)
|
2014-01-21 |
2022-04-21 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
|
US10016394B2
(en)
|
2014-04-16 |
2018-07-10 |
The Scripps Research Institute |
PPARG modulators for treatment of osteoporosis
|
|
CA2952557A1
(en)
*
|
2014-07-16 |
2016-01-21 |
Novogen ltd |
Functionalised and substituted indoles as anti-cancer agents
|
|
WO2016028971A1
(en)
*
|
2014-08-21 |
2016-02-25 |
Bristol-Myers Squibb Company |
Tied-back benzamide derivatives as potent rock inhibitors
|
|
JP2017526706A
(ja)
*
|
2014-09-10 |
2017-09-14 |
エピザイム，インコーポレイティド |
イソオキサゾールカルボキサミド化合物
|
|
EP3341357A4
(en)
*
|
2015-08-28 |
2019-03-27 |
Glenmark Pharmaceuticals S.A. |
NOVEL CARBOCYCLIC COMPOUNDS AS ROR GAMMA MODULATORS
|
|
WO2017157873A1
(en)
|
2016-03-17 |
2017-09-21 |
F. Hoffmann-La Roche Ag |
5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar
|
|
CN108815167B
(zh)
*
|
2017-05-24 |
2021-04-13 |
四川晶华生物科技有限公司 |
一种化合物在制备治疗肿瘤的药物中的用途
|
|
TW202136238A
(zh)
*
|
2020-01-06 |
2021-10-01 |
大陸商廣東東陽光藥業有限公司 |
RORγt抑制劑及其製備方法和用途
|
|
WO2022150962A1
(en)
*
|
2021-01-12 |
2022-07-21 |
Westlake Pharmaceutical (Hangzhou) Co., Ltd. |
Protease inhibitors, preparation, and uses thereof
|
|
CN115160269A
(zh)
*
|
2021-04-02 |
2022-10-11 |
北京大学 |
芳甲酰胺类衍生物作为nmdar的正性变构调节剂
|
|
IL314330A
(en)
|
2022-01-18 |
2024-09-01 |
Maze Therapeutics Inc |
Apol1 inhibitors and methods of use
|